大腸標的ドラッグデリバリーの世界市場レポート 2025年

大腸標的ドラッグデリバリーの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.3％で20億7,000万米ドルに成長します。この予測期間における成長は、刺激応答性およびナノテクノロジーに基づくデリバリーシステムの開発、受託研究開発および製造サービスの拡大、規制当局によるインセンティブの提供と承認経路の迅速化、生物製剤およびバイオシミラーの標的送達に起因すると考えられます。この間の主な動向としては、pH応答性システムの進歩、個別化医療の統合、製剤設計におけるAIやデジタルツールの活用、経口での大腸送達への注目の高まりなどが挙げられます。

消化器疾患の有病率の増加は、大腸標的ドラッグデリバリー市場の拡大を促進すると予想されます。胃、腸、関連臓器を含む消化器系に影響を及ぼす胃腸疾患は、加工食品の多量摂取や食物繊維の低摂取といった不健康な食習慣のために一般的になりつつあります。このような習慣は腸の健康や消化を乱し、炎症性腸疾患（IBD）などの疾患の増加につながります。大腸標的ドラッグデリバリーは、薬剤が炎症や感染部位で正確に放出され、治療効果を高め、全身的な副作用を最小限に抑えるために使用されています。例えば、2023年6月、Crohn's and Colitis Canadaは、炎症性腸疾患の罹患者数が2023年の32万2,600人（人口の0.8％）から2035年には47万人（人口の1.1％）に増加すると予測していると報告しています。このような消化器疾患の有病率の増加が、大腸標的ドラッグデリバリーソリューションの需要を促進しています。

大腸標的ドラッグデリバリー市場の各社は、標的薬物の放出を改善し、治療効果を高め、副作用を軽減する先進ソリューションの開発に注力しています。そのようなイノベーションの一つが機能性経口剤形の開発であり、これは上部消化管での分解から医薬品有効成分（API）を保護し、大腸での放出制御を確実にするように設計されています。2024年9月、ドイツの特殊化学品メーカーであるEvonik Industries AGは、大腸への経口ドラッグデリバリーを可能にする、すぐに充填できるカプセル技術、EUDRACAP Functionalを発表しました。この技術は、特定の腸内pHレベルでのみ溶解するpH感受性ポリマーを使用し、原薬がそのまま大腸に到達することを保証します。EUDRACAP Functionalは、ペプチドやプロバイオティクスなどの複雑な原薬の経口送達をサポートすることで、慢性消化器疾患に対する患者に優しい治療法の開発を支援し、より高い精度と全身曝露の低減を実現します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の大腸標的ドラッグデリバリーのPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の大腸標的ドラッグデリバリー市場：成長率分析
• 世界の大腸標的ドラッグデリバリー市場の実績：規模と成長、2019～2024年
• 世界の大腸標的ドラッグデリバリー市場の予測：規模と成長、2024～2029年、2034年
• 世界の大腸標的ドラッグデリバリー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の大腸標的ドラッグデリバリー市場：剤形別、実績と予測、2019～2024年、2024～2029年、2034年
• 錠剤
• カプセル
• マイクロスフェア
• ナノ粒子
• その他
• 世界の大腸標的ドラッグデリバリー市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• pH感受性システム
• 時間制御システム
• 微生物誘導システム
• 圧力制御システム
• その他
• 世界の大腸標的ドラッグデリバリー市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 炎症性腸疾患
• 大腸がん
• 感染症
• その他
• 世界の大腸標的ドラッグデリバリー市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• 研究機関
• その他
• 世界の大腸標的ドラッグデリバリー市場：錠剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 徐放錠
• 腸溶錠
• 浸透圧ポンプ錠
• 世界の大腸標的ドラッグデリバリー市場：カプセルのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ハードゼラチンカプセル
• ソフトゼラチンカプセル
• 腸溶性カプセル
• 世界の大腸標的ドラッグデリバリー市場：マイクロスフェアのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ポリマーマイクロスフェア
• 生分解性マイクロスフェア
• 非生分解性マイクロスフェア
• 世界の大腸標的ドラッグデリバリー市場：ナノ粒子のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ポリマーナノ粒子
• 固体脂質ナノ粒子
• デンドリマー
• 脂質ポリマーハイブリッドナノ粒子
• 世界の大腸標的ドラッグデリバリー市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• フィルム
• 注射
• ハイドロゲル
• 坐薬

第7章 地域別・国別分析

• 世界の大腸標的ドラッグデリバリー市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の大腸標的ドラッグデリバリー市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 大腸標的ドラッグデリバリー市場：競合情勢
• 大腸標的ドラッグデリバリー市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca plc
• Novartis AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Evonik Industries AG
• Teva Pharmaceutical Industries Ltd.
• Baxter International Inc.
• Lonza Pharma AG
• Ferring Pharmaceuticals Company Limited
• Salix Pharmaceuticals Ltd.
• Tillotts Pharma AG
• BDD Pharma Ltd.
• Tharimmune Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 大腸標的ドラッグデリバリー市場2029年：新たな機会を提供する国
• 大腸標的ドラッグデリバリー市場2029年：新たな機会を提供するセグメント
• 大腸標的ドラッグデリバリー市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Colon targeting drug delivery refers to a specialized system designed to release therapeutic agents directly in the colon, enhancing treatment effectiveness for local diseases such as inflammatory bowel disease and colorectal cancer. This approach minimizes systemic side effects and improves patient compliance.

The main dosage forms for colon-targeted drug delivery include tablets, capsules, microspheres, nanoparticles, and others. Tablets are solid, compressed forms of medication intended for oral intake. In colon-targeted delivery, these tablets are often coated with materials that prevent dissolution in the stomach or small intestine, ensuring the drug is released specifically in the colon. Various technologies are used in these systems, including pH-sensitive systems, time-dependent systems, microbially triggered systems, pressure-controlled systems, and others. These systems are applied in treating conditions such as inflammatory bowel disease, colorectal cancer, infectious diseases, and more. They are primarily utilized by end users such as hospitals, clinics, research institutes, and other healthcare settings.

The colon targeted drug delivery market research report is one of a series of new reports from The Business Research Company that provides colon targeted drug delivery market statistics, including the colon targeted drug delivery industry's global market size, regional shares, competitors with a colon targeted drug delivery market share, detailed colon targeted drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the colon targeted drug delivery industry. This colon targeted drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The colon targeting drug delivery market size has grown strongly in recent years. It will grow from$1.39 billion in 2024 to $1.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to the rising prevalence of colorectal diseases, an increased focus on localized drug delivery, the need for improved patient compliance, and the emergence of biologics and peptides in treatment options.

The colon targeting drug delivery market size is expected to see strong growth in the next few years. It will grow to$2.07 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the development of stimuli-responsive and nanotechnology-based delivery systems, the expansion of contract research and manufacturing services, regulatory agencies providing incentives and faster approval pathways, and the targeted delivery of biologics and biosimilars. Key trends during this period include advancements in pH-responsive systems, the integration of personalized medicine, the use of AI and digital tools in formulation design, and an increasing focus on oral colon delivery.

The increasing prevalence of gastrointestinal diseases is expected to drive the expansion of the colon targeting drug delivery market. Gastrointestinal diseases, which affect the digestive system including the stomach, intestines, and related organs, are becoming more common due to unhealthy dietary habits, such as high consumption of processed foods and low fiber intake. These habits disrupt gut health and digestion, leading to a rise in conditions such as inflammatory bowel disease (IBD). Colon targeting drug delivery is being used to ensure that drugs are precisely released at the site of inflammation or infection, increasing therapeutic effectiveness and minimizing systemic side effects. For example, in June 2023, Crohn's and Colitis Canada reported that the number of people affected by inflammatory bowel disease is projected to rise from 322,600 in 2023 (0.8% of the population) to 470,000 by 2035 (1.1% of the population). This growing prevalence of gastrointestinal diseases is driving demand for colon-targeting drug delivery solutions.

Companies in the colon targeting drug delivery market are focusing on developing advanced solutions that improve targeted drug release, enhance therapeutic efficacy, and reduce side effects. One such innovation is the development of functional oral dosage forms, which are designed to protect active pharmaceutical ingredients (APIs) from degradation in the upper gastrointestinal tract, ensuring their controlled release in the colon. In September 2024, Evonik Industries AG, a Germany-based specialty chemicals company, launched EUDRACAP Functional, a ready-to-fill capsule technology that enables the precise delivery of oral drugs to the colon. This technology uses pH-sensitive polymers that dissolve only at specific intestinal pH levels, ensuring that the API reaches the colon intact. By supporting the oral delivery of complex APIs such as peptides and probiotics, EUDRACAP Functional helps develop patient-friendly therapies for chronic gastrointestinal disorders, offering greater accuracy and reduced systemic exposure.

In October 2023, Roche Holding AG, a Switzerland-based healthcare company, acquired Telavant Holding Inc. for $7.1 billion. This acquisition strengthens Roche's position in the colon targeting drug delivery market by integrating Telavant's RVT-3101, a drug aimed at treating inflammatory bowel diseases. Telavant Holding Inc., a US-based biopharmaceutical company, specializes in developing therapies for gastrointestinal disorders. This strategic acquisition enhances Roche's ability to provide innovative treatments for gastrointestinal diseases, further advancing their portfolio in the field of colon-targeting drug delivery.

Major players in the colon targeting drug delivery market are Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Baxter International Inc., Lonza Pharma AG, Ferring Pharmaceuticals Company Limited, Salix Pharmaceuticals Ltd., Tillotts Pharma AG, BDD Pharma Ltd., and Tharimmune Inc.

North America was the largest region in the colon targeting drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in colon targeting drug delivery report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the colon targeting drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The colon targeting drug delivery market includes revenues earned by entities by providing services such as formulation development, preformulation studies, drug delivery technology licensing, coating and encapsulation services, and in-vitro release testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Colon Targeting Drug Delivery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on colon targeting drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for colon targeting drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The colon targeting drug delivery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Dosage Form: Tablets; Capsules; Microspheres; Nanoparticles; Other Dosage Form
• 2) By Technology: pH-Sensitive Systems; Time-Dependent Systems; Microbially Triggered Systems; Pressure-Controlled Systems; Other Technologies
• 3) By Application: Inflammatory Bowel Disease; Colorectal Cancer; Infectious Diseases; Other Application
• 4) By End-User: Hospitals; Clinics; Research Institutes; Other End-Users
• Subsegments:
• 1) By Tablets: Extended-Release Tablets; Enteric-Coated Tablets; Osmotic Pump Tablets
• 2) By Capsules: Hard Gelatin Capsules; Soft Gelatin Capsules; Enteric-Coated Capsules
• 3) By Microspheres: Polymeric Microspheres; Biodegradable Microspheres; Non-biodegradable Microspheres
• 4) By Nanoparticles: Polymeric Nanoparticles, Solid Lipid Nanoparticles, Dendrimers, Lipid-Polymer Hybrid Nanoparticles
• 4) By Other Dosage Form: Films; Injections; Hydrogels; Suppositories
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; AbbVie Inc.; Bayer AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Colon Targeting Drug Delivery Market Characteristics

3. Colon Targeting Drug Delivery Market Trends And Strategies

4. Colon Targeting Drug Delivery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Colon Targeting Drug Delivery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Colon Targeting Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Colon Targeting Drug Delivery Market Growth Rate Analysis
• 5.4. Global Colon Targeting Drug Delivery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Colon Targeting Drug Delivery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Colon Targeting Drug Delivery Total Addressable Market (TAM)

6. Colon Targeting Drug Delivery Market Segmentation

• 6.1. Global Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Microspheres
• Nanoparticles
• Other Dosage Form
• 6.2. Global Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• pH-Sensitive Systems
• Time-Dependent Systems
• Microbially Triggered Systems
• Pressure-Controlled Systems
• Other Technologies
• 6.3. Global Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inflammatory Bowel Disease
• Colorectal Cancer
• Infectious Diseases
• Other Application
• 6.4. Global Colon Targeting Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Research Institutes
• Other End-Users
• 6.5. Global Colon Targeting Drug Delivery Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Extended-Release Tablets
• Enteric-Coated Tablets
• Osmotic Pump Tablets
• 6.6. Global Colon Targeting Drug Delivery Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hard Gelatin Capsules
• Soft Gelatin Capsules
• Enteric-Coated Capsules
• 6.7. Global Colon Targeting Drug Delivery Market, Sub-Segmentation Of Microspheres, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymeric Microspheres
• Biodegradable Microspheres
• Non-biodegradable Microspheres
• 6.8. Global Colon Targeting Drug Delivery Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymeric Nanoparticles
• Solid Lipid Nanoparticles
• Dendrimers
• Lipid-Polymer Hybrid Nanoparticles
• 6.9. Global Colon Targeting Drug Delivery Market, Sub-Segmentation Of Other Dosage Form, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Films
• Injections
• Hydrogels
• Suppositories

7. Colon Targeting Drug Delivery Market Regional And Country Analysis

• 7.1. Global Colon Targeting Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Colon Targeting Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Colon Targeting Drug Delivery Market

• 8.1. Asia-Pacific Colon Targeting Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Colon Targeting Drug Delivery Market

• 9.1. China Colon Targeting Drug Delivery Market Overview
• 9.2. China Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Colon Targeting Drug Delivery Market

• 10.1. India Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Colon Targeting Drug Delivery Market

• 11.1. Japan Colon Targeting Drug Delivery Market Overview
• 11.2. Japan Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Colon Targeting Drug Delivery Market

• 12.1. Australia Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Colon Targeting Drug Delivery Market

• 13.1. Indonesia Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Colon Targeting Drug Delivery Market

• 14.1. South Korea Colon Targeting Drug Delivery Market Overview
• 14.2. South Korea Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Colon Targeting Drug Delivery Market

• 15.1. Western Europe Colon Targeting Drug Delivery Market Overview
• 15.2. Western Europe Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Colon Targeting Drug Delivery Market

• 16.1. UK Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Colon Targeting Drug Delivery Market

• 17.1. Germany Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Colon Targeting Drug Delivery Market

• 18.1. France Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Colon Targeting Drug Delivery Market

• 19.1. Italy Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Colon Targeting Drug Delivery Market

• 20.1. Spain Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Colon Targeting Drug Delivery Market

• 21.1. Eastern Europe Colon Targeting Drug Delivery Market Overview
• 21.2. Eastern Europe Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Colon Targeting Drug Delivery Market

• 22.1. Russia Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Colon Targeting Drug Delivery Market

• 23.1. North America Colon Targeting Drug Delivery Market Overview
• 23.2. North America Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Colon Targeting Drug Delivery Market

• 24.1. USA Colon Targeting Drug Delivery Market Overview
• 24.2. USA Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Colon Targeting Drug Delivery Market

• 25.1. Canada Colon Targeting Drug Delivery Market Overview
• 25.2. Canada Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Colon Targeting Drug Delivery Market

• 26.1. South America Colon Targeting Drug Delivery Market Overview
• 26.2. South America Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Colon Targeting Drug Delivery Market

• 27.1. Brazil Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Colon Targeting Drug Delivery Market

• 28.1. Middle East Colon Targeting Drug Delivery Market Overview
• 28.2. Middle East Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Colon Targeting Drug Delivery Market

• 29.1. Africa Colon Targeting Drug Delivery Market Overview
• 29.2. Africa Colon Targeting Drug Delivery Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Colon Targeting Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Colon Targeting Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Colon Targeting Drug Delivery Market Competitive Landscape And Company Profiles

• 30.1. Colon Targeting Drug Delivery Market Competitive Landscape
• 30.2. Colon Targeting Drug Delivery Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Colon Targeting Drug Delivery Market Other Major And Innovative Companies

• 31.1. AstraZeneca plc
• 31.2. Novartis AG
• 31.3. GlaxoSmithKline plc
• 31.4. Takeda Pharmaceutical Company Limited
• 31.5. Eli Lilly and Company
• 31.6. Amgen Inc.
• 31.7. Evonik Industries AG
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Baxter International Inc.
• 31.10. Lonza Pharma AG
• 31.11. Ferring Pharmaceuticals Company Limited
• 31.12. Salix Pharmaceuticals Ltd.
• 31.13. Tillotts Pharma AG
• 31.14. BDD Pharma Ltd.
• 31.15. Tharimmune Inc.

32. Global Colon Targeting Drug Delivery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Colon Targeting Drug Delivery Market

34. Recent Developments In The Colon Targeting Drug Delivery Market

35. Colon Targeting Drug Delivery Market High Potential Countries, Segments and Strategies

• 35.1 Colon Targeting Drug Delivery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Colon Targeting Drug Delivery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Colon Targeting Drug Delivery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer